Regulation (EU) 2019/6 on veterinary medicinal products allows medicinal products to be used outside the terms of their marketing authorisation under certain conditions when no suitable authorised product is available. This is often often referred to as ‘cascade use’. However, in the specific case of antimicrobials, Article 107(6) of the regulation makes provisions for a list of antimicrobials that may not be used under the cascade, or may only be used subject to certain conditions.
The European Commission has asked the European Medicines Agency (EMA) to provide scientific advice on how to address these provisions in forthcoming additional legislation.
The Committee for Medicinal Products for Veterinary Use (CVMP) invites all interested parties, including pharmaceutical industry, veterinarians, professional groups, learned societies, governmental institutions as well as EU and EEA Member States to submit information on cascade use of antimicrobials in animals and any scientific evidence of an impact on public and animal health that the CVMP should consider in the preparation of its scientific advice.
The consultation will close on 6 March 2020.
To submit information, use below questionnaire:
https://ec.europa.eu/eusurvey/runner/OpenCallUseofantimicrobialsinanimals
